Transmembrane protein differentially expressed in cancer
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Sep 12, 2006
Grant Date -
Apr 10, 2003
app pub date -
Jul 1, 2002
filing date -
Jun 16, 1999
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The invention provides a transmembrane protein that is differentially expressed in neoplastic disorders. It also provides for the use of the protein, a cDNA encoding the protein, and antibodies that specifically bind the protein in various methods to diagnose, stage, treat, or monitor the treatment of a neoplastic disorder.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully